A carregar...
Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections
Neutralization of IFN-γ with emapalumab can reverse severe, refractory hemophagocytic lymphohistiocytosis. Neutralizing IFN-γ did not impair control of multiple viral and other infections in a severely ill patient.
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6325304/ https://ncbi.nlm.nih.gov/pubmed/30617216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018025858 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|